Meeting
2021 Gastrointestinal Cancers Symposium
Selecting the optimal neoadjuvant treatment approach based on the risk of an involved surgical margin in locally advanced adenocarcinoma of the esophagus and esophagogastric junction.
Authors
Tim Spencer
University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
Tim Spencer , Jonathan Helbrow , Eleanor Pilsworth , Stephen Falk , Helen Winter , Thomas Bird
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session: Esophageal and Gastric Cancer
Track
Esophageal and Gastric Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 39, 2021 (suppl 3; abstr 198)
DOI
10.1200/JCO.2021.39.3_suppl.198
Abstract #
198
Poster Bd #
Online Only
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
A novel gene signature for predicting response to chemoradiotherapy in locally advanced esophageal adenocarcinoma.
First Author: Divya Sahu
Poster
2018 Gastrointestinal Cancers Symposium
A phase II study of durvalumab following multimodality therapy for locally advanced esophageal adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-ESO14-012 study.
First Author: Hirva Mansurali Mamdani
Poster
2024 ASCO Annual Meeting
Phase II trial of immunotherapeutic HPV vaccine PRGN-2009 with pembrolizumab before standard treatment in subjects with newly diagnosed HPV-associated oropharyngeal cancer.
First Author: Dara Mark Bracken-Clarke
Poster
2023 ASCO Annual Meeting
Multimodal detection in plasma of molecular residual disease (MRD) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
First Author: Enrique Sanz Garcia